Mark Brower is currently a member of the Downstream Process Development and Engineering group within the Biologics and Vaccines Development organization. There, he is responsible for leading a team of scientists investigating novel upstream and downstream initiatives towards a low cost protein production platform including perfusion cell culture, continuous biomanufacturing and single-use systems. Prior to this, Mark has developed purification processes for both natural product secondary metabolites and small molecule enzymatic biotransformations. Mark earned his BS in Chemical Engineering from The Pennsylvania State University, and a PhD in the same field from Cambridge University.
Principal Scientist, Downstream Process Development & Engineering